Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease

Deciphering the Function and Regulation of microRNAs in Alzheimer’s Disease and Parkinson’s Disease

(2014) Lifeng Qiu et al.   ACS Chemical Neuroscience

Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease

(2014) Falk Schlaudraff et al.   NEUROBIOLOGY OF AGING

Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b

(2014) Izaskun Villar-Menéndez et al.   NEUROBIOLOGY OF DISEASE

Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls

(2013) Lucía F. Cardo et al.   JOURNAL OF NEUROLOGY

SNP rs356219 of the α-synuclein (SNCA) gene is associated with Parkinson’s disease in a Chinese Han population

(2012) Fenghua Pan et al.   PARKINSONISM & RELATED DISORDERS

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

(2011) Elena Miñones-Moyano et al.   HUMAN MOLECULAR GENETICS

MicroRNAs in Parkinson's disease

(2011) Maged M. Harraz et al.   JOURNAL OF CHEMICAL NEUROANATOMY

MicroRNAs in neurodegenerative diseases and their therapeutic potential

(2011) Eunsung Junn et al.   PHARMACOLOGY & THERAPEUTICS

Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease

(2011) Madalena Martins et al.   PLoS One

SNP rs7684318 of the α-synuclein gene is associated with Parkinson's disease in the Han Chinese population

(2010) Lihua Yu et al.   BRAIN RESEARCH

Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153

(2010) Epaminondas Doxakis   JOURNAL OF BIOLOGICAL CHEMISTRY

Global microRNA Expression Profiling of Caenorhabditis elegans Parkinson's Disease Models

(2010) Suvi Asikainen et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

FGF20 rs12720208 SNP and microRNA-433 variation: No association with Parkinson's disease in Spanish patients

(2010) Lorena de Mena et al.   NEUROSCIENCE LETTERS

Defining Larger Roles for “Tiny” RNA Molecules: Role of miRNAs in Neurodegeneration Research

(2009) Sowmya V. Yelamanchili et al.   Journal of Neuroimmune Pharmacology

FGF20and Parkinson's disease: No evidence of association or pathogenicity via α-synuclein expression

(2009) Christian Wider et al.   MOVEMENT DISORDERS

Repression of  -synuclein expression and toxicity by microRNA-7

(2009) E. Junn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-Synuclein

(2008) Gaofeng Wang et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Elevated α-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease

(2008) Jan Gründemann et al.   NUCLEIC ACIDS RESEARCH